Explore the fascinating phenomenon of HLA loss in leukemia relapses after partially-incompatible stem cell transplants and the crucial role of natural killer cells in cancer immunotherapy.
Discover how scientists are targeting CD25 on leukemic stem cells to develop new treatments for Chronic Myeloid Leukemia (CML).
Exploring ONC201's unexpected efficacy against relapsed leukemias through DRD2 antagonism and mitochondrial targeting in clinical trials.
Discover how hypermethylation of HOX genes contributes to myeloid and lymphoid malignancies and impacts patient prognosis.